At first glance, the GLP-1 era should be hostile to chocolate. A Cornell analysis published in December 2025 found that, within six months of starting a GLP-1 medication, U.S. households cut grocery spending by an average of 5.3%, with especially large declines in sweets, baked goods, cookies, and savory snacks. Yet in March 2026 Lindt & Sprüngli reported that, in its Circana-based U.S. analysis, premium chocolate sales rose by nearly 17% among GLP-1 users in 2025, compared with 6.5% among non-users; those households accounted for about 15% of households but 17.5% of chocolate sales. Because that chocolate result comes from a company analysis, it is best read as a striking market signal rather than a universal law. (news.cornell.edu)
The paradox becomes less mysterious once we distinguish appetite suppression from the total extinction of pleasure. In the STEP 5 trial, semaglutide improved craving control and reduced difficulty resisting cravings over 104 weeks in adults with overweight or obesity. A 2025 Japanese study likewise found that semaglutide lowered preferences for sweet carbohydrates, staple foods such as white rice and udon or soba, and high-fat snacks. In other words, GLP-1 drugs appear to narrow desire, not abolish it. That suggests a shift from impulsive quantity to curated intensity: one excellent truffle can survive where a whole bag of mediocre candy no longer makes sense. This final point is an inference from the clinical and purchasing data, not a direct causal proof. (pubmed.ncbi.nlm.nih.gov)
So the real story is not that weight-loss-drug users are secretly reverting to old habits. It is that the surviving indulgence becomes more ceremonial, more legible, and often more expensive per bite. When everyday snacking recedes, the treat must justify itself. Premium chocolate, with its small portions, intense flavor, and aura of reward, fits that new psychology almost perfectly. In the GLP-1 economy, then, “less” does not necessarily mean “none”; quite often, it means “better.” (lindt-spruengli.com)










